Commentary on new xenobiotic immunosuppressants for transplantation: Where are we, how did we get here, and where are we going?

R E Morris
Author Information
  1. R E Morris: Laboratory for Transplantation Immunology, Department of Cardiothoracic Surgery, Stanford University Medical School, CA.

Abstract

No abstract text available.

MeSH Term

Autoimmune Diseases
Drug Evaluation
Forecasting
Graft Rejection
Humans
Immunosuppression Therapy
Immunosuppressive Agents
Transplantation, Heterologous
Xenobiotics

Chemicals

Immunosuppressive Agents
Xenobiotics

Word Cloud

Created with Highcharts 10.0.0Commentarynewxenobioticimmunosuppressantstransplantation:getgoing?

Similar Articles

Cited By